Nicolas Masurier

1.1k total citations
55 papers, 877 citations indexed

About

Nicolas Masurier is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, Nicolas Masurier has authored 55 papers receiving a total of 877 indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Organic Chemistry, 36 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Nicolas Masurier's work include Chemical Synthesis and Analysis (18 papers), Synthesis and biological activity (11 papers) and Cancer therapeutics and mechanisms (10 papers). Nicolas Masurier is often cited by papers focused on Chemical Synthesis and Analysis (18 papers), Synthesis and biological activity (11 papers) and Cancer therapeutics and mechanisms (10 papers). Nicolas Masurier collaborates with scholars based in France, Egypt and Saudi Arabia. Nicolas Masurier's co-authors include Jean Martínez, Vincent Lisowski, Ludovic T. Maillard, Olivier Lafont, Baptiste Legrand, François Estour, Muriel Amblard, Emmanuel Moreau, Patrick Masson and Chahrazade El Amri and has published in prestigious journals such as Angewandte Chemie International Edition, Chemical Communications and Journal of Medicinal Chemistry.

In The Last Decade

Nicolas Masurier

53 papers receiving 868 citations

Peers

Nicolas Masurier

MICRO

ONCOL

Débora Braga Vieira Brazil

Luisa Ronga France

Neil J. Hales United Kingdom

Sharon Tentarelli United States

Lionel Nauton France

Lijing Fang China

Wilma Neumann Germany

Daniel Dowling United States

Raphaël Labruère France

Mirosława Koronkiewicz Poland

Débora Braga Vieira Brazil

Nicolas Masurier

242 ×0.4

293 ×0.7

52 ×0.7

MICRO

45 ×0.6

ONCOL

16 ×0.2

Citations per year, relative to Nicolas Masurier Nicolas Masurier (= 1×) peers Débora Braga Vieira

Countries citing papers authored by Nicolas Masurier

Since Specialization

Citations

This map shows the geographic impact of Nicolas Masurier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolas Masurier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolas Masurier more than expected).

Fields of papers citing papers by Nicolas Masurier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicolas Masurier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolas Masurier. The network helps show where Nicolas Masurier may publish in the future.

Co-authorship network of co-authors of Nicolas Masurier

This figure shows the co-authorship network connecting the top 25 collaborators of Nicolas Masurier. A scholar is included among the top collaborators of Nicolas Masurier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicolas Masurier. Nicolas Masurier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Favre, Luc, et al.. (2025). Vegetable Oil‐Based Materials for Drug Delivery Systems and Wound Dressings. Macromolecular Bioscience. 26(3). e00486–e00486.

El‐Haggar, Radwan, et al.. (2025). Amino acid–modified chalcone derivatives with in vitro and in vivo efficacy against colon cancer. European Journal of Medicinal Chemistry. 297. 117963–117963. 1 indexed citations

Shaldam, Moataz A., Radwan El‐Haggar, Taghreed A. Majrashi, et al.. (2023). 2,4-Diaryl-pyrimido[1,2-a]benzimidazole derivatives as novel anticancer agents endowed with potent anti-leukemia activity: Synthesis, biological evaluation and kinase profiling. European Journal of Medicinal Chemistry. 258. 115610–115610. 19 indexed citations

Ahmed, Marwa F., Samar S. Fatahala, Eman F. Khaleel, et al.. (2023). Novel N -Arylmethyl-aniline/chalcone hybrids as potential VEGFR inhibitors: synthesis, biological evaluations, and molecular dynamic simulations. Journal of Enzyme Inhibition and Medicinal Chemistry. 38(1). 2278022–2278022. 3 indexed citations

Masurier, Nicolas, et al.. (2023). Recent advances in aza Friedel–Crafts reaction: strategies for achiral and stereoselective synthesis. Organic Chemistry Frontiers. 10(7). 1847–1866. 23 indexed citations

Amanzougaghene, Nadia, Sébastien Hutter, Jean‐François Franetich, et al.. (2023). New antiplasmodial 4-amino-thieno[3,2-d]pyrimidines with improved intestinal permeability and microsomal stability. European Journal of Medicinal Chemistry. 249. 115115–115115. 6 indexed citations

Hutter, Sébastien, Jean‐François Franetich, Aurélie Malzert‐Fréon, et al.. (2023). Novel thienopyrimidones targeting hepatic and erythrocytic stages of Plasmodium parasites with increased microsomal stability. European Journal of Medicinal Chemistry. 261. 115873–115873. 2 indexed citations

Eissa, Ibrahim H., Radwan El‐Haggar, Mohammed A. Dahab, et al.. (2022). Design, synthesis, molecular modeling and biological evaluation of novel Benzoxazole-Benzamide conjugates via a 2-Thioacetamido linker as potential anti-proliferative agents, VEGFR-2 inhibitors and apoptotic inducers. Journal of Enzyme Inhibition and Medicinal Chemistry. 37(1). 1587–1599. 17 indexed citations

Amanzougaghene, Nadia, Sébastien Hutter, Jean‐François Franetich, et al.. (2022). 4-Substituted Thieno[3,2-d]pyrimidines as Dual-Stage Antiplasmodial Derivatives. Pharmaceuticals. 15(7). 820–820. 4 indexed citations

10.

Hutter, Sébastien, Nadia Amanzougaghene, Jean‐François Franetich, et al.. (2022). Synthesis of antiplasmodial 2-aminothieno[3,2-d]pyrimidin-4(3H)-one analogues using the scaffold hopping strategy. European Journal of Medicinal Chemistry. 241. 114619–114619. 5 indexed citations

11.

El‐Haggar, Radwan, Sherif Hammad, Reem I. Alsantali, et al.. (2022). 3-Substituted-2,3-Dihydrothiazole as a promising scaffold to design EGFR inhibitors. Bioorganic Chemistry. 129. 106172–106172. 7 indexed citations

12.

Fersing, Cyril, et al.. (2021). Thienopyrimidine: A Promising Scaffold to Access Anti-Infective Agents. Pharmaceuticals. 15(1). 35–35. 35 indexed citations

13.

Ali, Lamiaa M. A., et al.. (2020). Imidazopyridine-fused [1,3]diazepinones: modulations of positions 2 to 4 and their impacts on the anti-melanoma activity. Journal of Enzyme Inhibition and Medicinal Chemistry. 35(1). 935–949. 10 indexed citations

14.

Peyressatre, Marion, Juan A. González‐Vera, Morgan Pellerano, et al.. (2020). Identification of Quinazolinone Analogs Targeting CDK5 Kinase Activity and Glioblastoma Cell Proliferation. Frontiers in Chemistry. 8. 691–691. 13 indexed citations

15.

Bellet, Virginie, Audrey Gallud, Vincent Lisowski, et al.. (2016). Imidazopyridine-fused [1,3]-diazepinones part 2: Structure-activity relationships and antiproliferative activity against melanoma cells. European Journal of Medicinal Chemistry. 125. 1225–1234. 17 indexed citations

16.

Lisowski, Vincent, et al.. (2015). Pyrido-imidazodiazepinones as a new class of reversible inhibitors of human kallikrein 7. European Journal of Medicinal Chemistry. 93. 202–213. 18 indexed citations

17.

Legrand, Baptiste, Aurélien Lebrun, Vincent Lisowski, et al.. (2014). Thiazole‐Based γ‐Building Blocks as Reverse‐Turn Mimetic to Design a Gramicidin S Analogue: Conformational and Biological Evaluation. Chemistry - A European Journal. 20(22). 6713–6720. 38 indexed citations

18.

Gallud, Audrey, Ophélie Vaillant, Ludovic T. Maillard, et al.. (2014). Imidazopyridine-fused [1,3]-diazepinones: Synthesis and antiproliferative activity. European Journal of Medicinal Chemistry. 75. 382–390. 41 indexed citations

19.

Maillard, Ludovic T., Sébastien Bertout, Ophélie Quinonero, et al.. (2013). Synthesis and anti-Candida activity of novel 2-hydrazino-1,3-thiazole derivatives. Bioorganic & Medicinal Chemistry Letters. 23(6). 1803–1807. 37 indexed citations

20.

Moreau, Emmanuel, Nicolas Masurier, Jacques Lacroix, et al.. (2008). Novel imidazo[1,2-a]naphthyridinic systems (part 1): Synthesis, antiproliferative and DNA-intercalating activities. European Journal of Medicinal Chemistry. 43(11). 2505–2517. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact